Implications of curative pancreatectomy for pancreatic cancer with positive peritoneal washing cytology

Implications of curative pancreatectomy for pancreatic cancer with positive peritoneal washing cytology - Implications of curative pancreatectomy for pancreatic cancer with positive peritoneal washing cytology

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000023532

Enrollment

2500

Registered

2016-09-30

Start date

2016-10-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

pancreatic cancer

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients who underwent peritoneal washing cytology and curative resection

Exclusion criteria

Exclusion criteria: Patients who did not undergo peritoneal washing cytology

Design outcomes

Primary

Measure	Time frame
disease-specific survival	—

Secondary

Measure	Time frame
1. disease-free survival 2. recurrence, initial recurrence pattern 3. surgical results (ope time, blood loss, blood transfusion, length of hospital stay) 4. postoperative complications (overall complications, re-laparotomy, re-adimission) 5. Mortality (30-days and 90-days mortality) 6. Pathological findings (pathological type, lymph node metastasis, TNM staging)	—

Countries

Japan

Contacts

Public ContactTsutomu Fujii

Nagoya University Graduate School of Medicine Department of Gastroenterological Surgery (Surgery II)

fjt@med.nagoya-u.ac.jp052-744-2245

Outcome results